BRCA1 and breast cancer: Although some studies report elevated TILs in BRCA1/2 mutant breast cancer (21, 24), a pooled analysis of five phase II studies showed that TIL density was not associated with HR defect or BRCA1/2 mutation in early stage patients with TNBC (20).